Latest Transformation News

Imricor Medical Systems has achieved a major milestone with FDA clearance for its Vision-MR Diagnostic Catheter, paving the way for commercial sales in the US electrophysiology market.

Argosy Minerals has completed detailed engineering for a 40MW energy infrastructure project to supply its Rincon Lithium Project in Argentina, marking a key step towards commercialisation and cost efficiency.

Iltani Resources reports exceptional silver-indium assay results from its Orient Project’s Link Zone in Queensland, confirming potential to connect key mineral resources. Backed by a fresh $8 million investment, the company plans an aggressive drilling program to expand and upgrade its resource base in 2026.

Lunnon Metals has reported significant gold intercepts at its Paringa West prospect, confirming a promising new geological structure within the prolific St Ives gold camp. The results bolster the company’s exploration ambitions in Western Australia’s renowned Foster-Baker Project.

Green Technology Metals has extended its Letter of Interest with Export Development Canada for up to C$100 million in financing, reinforcing the strategic development of its Seymour Lithium Project in Ontario.

White Energy’s subsidiary BCBC has clinched an exclusive global agency agreement with Komarek to market briquettor machines using its proprietary BCB technology starting January 2026. This deal extends White Energy’s foothold in coal upgrading amid evolving energy markets.

Chariot Resources has signed a non-binding MOU with Fujian Jinjianqiao to explore offtake, financing, and local processing for its Nigerian lithium projects, aiming to accelerate commercialisation.

Alcidion has been named the preferred supplier for University Hospitals Sussex's new Electronic Patient Record system, with a contract expected to exceed A$35 million over seven years. This deal builds on an existing partnership and marks a significant expansion for Alcidion in the UK healthcare IT market.

Ramelius Resources confirms it is on track to meet its FY26 gold production guidance, with key projects progressing smoothly and a substantial share buyback program underway.

Montaka Global Fund – Active ETF (ASX – MOGL) has announced a distribution of 10.80 cents per unit for the quarter ending 31 December 2025, alongside details of its Distribution Reinvestment Plan and tax status.

Neuren Pharmaceuticals has published promising Phase 2 trial results for NNZ-2591 in Phelan-McDermid syndrome, underpinning its ongoing Phase 3 Koala trial recruiting in the US.

Bayan Mining has appointed Nathan Kong as its new CEO, bringing over 17 years of tier-one mining experience to lead its rare earth projects and strategic growth initiatives.